Compare Opendoor Technologies Inc (OPEN) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Opendoor Technologies Inc vs ResMed Inc. — how do they compare? Opendoor Technologies Inc trades at $3.02 (market cap $2.96B), while ResMed Inc. trades at $219.5 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 10.8× Opendoor Technologies Inc's market cap, and ResMed Inc. pays a 1.19% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| OPEN | RMD | |
|---|---|---|
Market Cap | $2.96B | $31.89B |
Sector | Real Estate | Health |
52-Week High | $10.52 | $283.28 |
52-Week Low | $3.00 | $182.82 |
Enterprise Value | $4.03B | $31.24B |
Dividend Yield | — | 1.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Opendoor Technologies (OPEN) trades at $3.07, down 2.54% on the day, near its 52-week low. The stock exhibits a bearish technical trend with negative moving averages, while fundamentals show declining revenue to $4.37 billion in 2025 and a net loss of $1.30 billion. Recent news highlights the launch of Opendoor Home Loans and a $158 million share buyback, but the company faces persistent profitability challenges amid a weak housing market.
The outlook remains cautious with high execution risks and negative margins, though analyst consensus suggests a moderate buy rating with a $3.58 price target. Key risks include housing market sensitivity and capital intensity, but cost-cutting and volume growth offer potential upside if the turnaround gains traction.
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
